Nordicus Partners (NORD) Research & Development (2009 - 2026)
Nordicus Partners (NORD) reported Research & Development of $437,885 for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 3.4% from $423,649 a year earlier and up 54.6% from the prior quarter.
Powered by 
Analysis
Nordicus Partners (NORD) Research & Development (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Nordicus Partners' Research & Development came in at $1.62 million, down 7.5% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $1.61 million, up 20.9% from FY2025.
- By fiscal year, Research & Development came in at $1.33 million in FY2025.
- Five-year quarterly Research & Development spans a low of $283,163 in fiscal Q4 2026 and a high of $568,419 in fiscal Q4 2025.
- Year over year, Research & Development gained in three of the last four quarters, with an average decline of 1.9%.
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $283,163 (Q4 2026), $445,459 (Q3 2026) and $454,701 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Nordicus Partners | 55.60 Mn | 55.07 Mn | - | 437,885.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 437,885.00 |
| Mar 31, 2026 | 283,163.00 |
| Dec 31, 2025 | 445,459.00 |
| Sep 30, 2025 | 454,701.00 |
| Jun 30, 2025 | 423,649.00 |
| Mar 31, 2025 | 568,419.00 |
| Dec 31, 2024 | 417,808.00 |
| Sep 30, 2024 | 343,209.00 |
| Mar 31, 2020 | 34,000.00 |
| Dec 31, 2019 | 103,000.00 |
| Sep 30, 2019 | 79,000.00 |
| Jun 30, 2019 | 98.00 |
| Mar 31, 2019 | -252,655.00 |
| Dec 31, 2018 | 77,000.00 |
| Sep 30, 2018 | 87,000.00 |
| Jun 30, 2018 | 88.00 |
| Mar 31, 2018 | -283,625.00 |
| Dec 31, 2017 | 87,000.00 |
| Sep 30, 2017 | 108,000.00 |
| Jun 30, 2017 | 89,000.00 |
API Access
Nordicus Partners Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NORD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NORD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NORD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();